Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

SEFFI is a safe and effective anti-aging treatment with few complications.

A U.S. Naval fighter pilot suffered permanent vision loss in one eye due to recurrent central serous retinopathy.

XP-endo Finisher R removes more root filling material than PUI in curved canals.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

KFSD causes scarring hair loss and skin roughness, mainly in males.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Fractional infrared technology is effective and safe for treating cervical laxity.

Radiation-induced hair loss may be caused by hair growth stopping and inflammation in blood vessels.

Red light increases hair follicles and ATP in mouse skin.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

FFA and FAPD might be related or stages of the same disease.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.